132 related articles for article (PubMed ID: 3754973)
1. The effect of an orally active leukotriene D4/E4 antagonist, LY171883, on antigen-induced airway responses in allergic sheep.
Abraham WM; Wanner A; Stevenson JS; Chapman GA
Prostaglandins; 1986 Mar; 31(3):457-67. PubMed ID: 3754973
[TBL] [Abstract][Full Text] [Related]
2. The effect of an orally active leukotriene (LT) D4 antagonist WY-48, 252 on LTD4 and antigen-induced bronchoconstrictions in allergic sheep.
Abraham WM; Stevenson JS; Garrido R
Prostaglandins; 1988 May; 35(5):733-45. PubMed ID: 3399681
[TBL] [Abstract][Full Text] [Related]
3. The effects of a cysteinyl leukotriene antagonist (ONO-1078) on antigen-induced responses in allergic sheep.
Abraham WM; Ahmed A; Cortes A; Sielczak M; Hallmon J
Prostaglandins Leukot Essent Fatty Acids; 1993 Mar; 48(3):233-9. PubMed ID: 8469683
[TBL] [Abstract][Full Text] [Related]
4. LY171883, 1-less than 2-hydroxy-3-propyl-4-less than 4-(1H-tetrazol-5-yl) butoxy greater than phenyl greater than ethanone, an orally active leukotriene D4 antagonist.
Fleisch JH; Rinkema LE; Haisch KD; Swanson-Bean D; Goodson T; Ho PP; Marshall WS
J Pharmacol Exp Ther; 1985 Apr; 233(1):148-57. PubMed ID: 3981452
[TBL] [Abstract][Full Text] [Related]
5. Effects of leukotriene D4 on mucociliary and respiratory function in allergic and nonallergic sheep.
Russi EW; Abraham WM; Chapman GA; Stevenson JS; Codias E; Wanner A
J Appl Physiol (1985); 1985 Nov; 59(5):1416-22. PubMed ID: 4066571
[TBL] [Abstract][Full Text] [Related]
6. Effect of the oral leukotriene D4 antagonist LY171883 on inhaled and intradermal challenge with antigen and leukotriene D4 in atopic subjects.
Fuller RW; Black PN; Dollery CT
J Allergy Clin Immunol; 1989 May; 83(5):939-44. PubMed ID: 2715552
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene (LT) receptor antagonists. Heterocycle-linked tetrazoles and carboxylic acids. LY203647.
Marshall WS; Sigmund SK; Whitesitt CA; Lifer SL; Roman CR; Rinkema LE; Hahn RA; Fleisch JH
Agents Actions; 1989 Jun; 27(3-4):309-12. PubMed ID: 2552762
[TBL] [Abstract][Full Text] [Related]
8. Leukotriene receptor antagonism and augmentation of beta-receptor-mediated events by LY171883.
Rinkema LE; Roman CR; Russell WL; Spaethe SM; Bemis KG; Henry DP; Marshall WS; Fleisch JH
J Pharm Pharmacol; 1990 Sep; 42(9):620-5. PubMed ID: 1706765
[TBL] [Abstract][Full Text] [Related]
9. The pharmacological evaluation of LY 170680, a novel leukotriene D4 and E4 antagonist in the guinea-pig.
Boot JR; Bond A; Gooderham R; O'Brien A; Parsons M; Thomas KH
Br J Pharmacol; 1989 Sep; 98(1):259-67. PubMed ID: 2553189
[TBL] [Abstract][Full Text] [Related]
10. Differences in airway responsiveness to leukotriene D4 in allergic sheep with and without late bronchial responses.
Abraham WM; Lanes S; Wanner A; Stevenson JS; Codias E; Yerger LD
Prostaglandins; 1986 Mar; 31(3):445-55. PubMed ID: 3715056
[TBL] [Abstract][Full Text] [Related]
11. Production of early and late pulmonary responses with inhaled leukotriene D4 in allergic sheep.
Abraham WM; Russi E; Wanner A; Delehunt JC; Yerger LD; Chapman GA
Prostaglandins; 1985 May; 29(5):715-26. PubMed ID: 3925500
[TBL] [Abstract][Full Text] [Related]
12. Separation of late bronchial responses from airway hyperresponsiveness in allergic sheep.
Solér M; Sielczak M; Abraham WM
J Appl Physiol (1985); 1991 Feb; 70(2):617-23. PubMed ID: 2022553
[TBL] [Abstract][Full Text] [Related]
13. Primate myocardial and systemic hemodynamic responses to leukotriene D4: antagonism by LY171883.
Hahn RA; MacDonald BR
J Pharmacol Exp Ther; 1987 Jul; 242(1):62-9. PubMed ID: 3612538
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of LY163443, 1-[2-hydroxy-3-propyl-4-([4- (1H-tetrazol-5-ylmethyl)phenoxy]methyl) phenyl]ethanone, as a pharmacologic antagonist of leukotrienes D4 and E4.
Fleisch JH; Rinkema LE; Haisch KD; McCullough D; Carr FP; Dillard RD
Naunyn Schmiedebergs Arch Pharmacol; 1986 May; 333(1):70-7. PubMed ID: 3016562
[TBL] [Abstract][Full Text] [Related]
15. Dose-related antagonism of leukotriene D4-induced bronchoconstriction by p.o. administration of LY-171883 in nonasthmatic subjects.
Phillips GD; Rafferty P; Robinson C; Holgate ST
J Pharmacol Exp Ther; 1988 Aug; 246(2):732-8. PubMed ID: 3404455
[TBL] [Abstract][Full Text] [Related]
16. The effect of an orally active leukotriene (LT) antagonist YM-16638 on antigen-induced early and late airway responses in allergic sheep.
Tomioka K; Garrido R; Stevenson JS; Abraham WM
Prostaglandins Leukot Essent Fatty Acids; 1989 Apr; 36(1):43-7. PubMed ID: 2740413
[TBL] [Abstract][Full Text] [Related]
17. Reversal of leukotriene D4- and leukotriene E4-induced airway constriction in the guinea pig.
Silbaugh SA; Stengel PW; Pechous PA; Marshall WS
Am Rev Respir Dis; 1989 Sep; 140(3):610-4. PubMed ID: 2571321
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of a leukotriene antagonist on endotoxin-induced acute hemodynamic alterations.
Etemadi AR; Tempel GE; Farah BA; Wise WC; Halushka PV; Cook JA
Circ Shock; 1987; 22(1):55-63. PubMed ID: 3038364
[TBL] [Abstract][Full Text] [Related]
19. The role of slow-reacting substance of anaphylaxis in the late bronchial response after antigen challenge in allergic sheep.
Delehunt JC; Perruchoud AP; Yerger L; Marchette B; Stevenson JS; Abraham WM
Am Rev Respir Dis; 1984 Nov; 130(5):748-54. PubMed ID: 6208832
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of a selective leukotriene antagonist in endotoxemia in the rat.
Cook JA; Wise WC; Halushka PV
J Pharmacol Exp Ther; 1985 Nov; 235(2):470-4. PubMed ID: 2997435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
